D. Riesenbeck

1.2k total citations
33 papers, 751 citations indexed

About

D. Riesenbeck is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology. According to data from OpenAlex, D. Riesenbeck has authored 33 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 21 papers in Oncology and 7 papers in Otorhinolaryngology. Recurrent topics in D. Riesenbeck's work include Oral health in cancer treatment (12 papers), Cancer Diagnosis and Treatment (11 papers) and Lung Cancer Diagnosis and Treatment (8 papers). D. Riesenbeck is often cited by papers focused on Oral health in cancer treatment (12 papers), Cancer Diagnosis and Treatment (11 papers) and Lung Cancer Diagnosis and Treatment (8 papers). D. Riesenbeck collaborates with scholars based in Germany, Netherlands and France. D. Riesenbeck's co-authors include Peter B. Lockhart, Michael T. Brennan, René‐Jean Bensadoun, Linda S. Elting, Fred K. L. Spijkervet, M Semik, Michael Thomas, Achim Heinecke, Michael W. Hamm and D. Ukena and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

D. Riesenbeck

27 papers receiving 728 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Riesenbeck Germany 10 583 288 269 114 90 33 751
Marjorie A. Larto United States 9 497 0.9× 517 1.8× 192 0.7× 35 0.3× 521 5.8× 12 931
Michael A. Samuels United States 12 141 0.2× 107 0.4× 159 0.6× 41 0.4× 93 1.0× 35 419
Frederick M. Schnell United States 8 136 0.2× 60 0.2× 199 0.7× 41 0.4× 192 2.1× 17 481
Aydın Yavuz Türkiye 10 130 0.2× 42 0.1× 81 0.3× 77 0.7× 92 1.0× 33 326
Stefano Lamon Italy 5 233 0.4× 133 0.5× 95 0.4× 3 0.0× 115 1.3× 8 445
Yukiko Takahashi Japan 12 77 0.1× 42 0.1× 71 0.3× 11 0.1× 116 1.3× 34 362
Juan Antonio Virizuela Spain 12 165 0.3× 11 0.0× 231 0.9× 38 0.3× 127 1.4× 57 587
Yoshihisa Yaguchi Japan 16 667 1.1× 13 0.0× 289 1.1× 14 0.1× 521 5.8× 58 1.0k
Honghai Guo China 14 277 0.5× 8 0.0× 193 0.7× 25 0.2× 171 1.9× 35 504

Countries citing papers authored by D. Riesenbeck

Since Specialization
Citations

This map shows the geographic impact of D. Riesenbeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Riesenbeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Riesenbeck more than expected).

Fields of papers citing papers by D. Riesenbeck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Riesenbeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Riesenbeck. The network helps show where D. Riesenbeck may publish in the future.

Co-authorship network of co-authors of D. Riesenbeck

This figure shows the co-authorship network connecting the top 25 collaborators of D. Riesenbeck. A scholar is included among the top collaborators of D. Riesenbeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Riesenbeck. D. Riesenbeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jahn, Patrick & D. Riesenbeck. (2017). Orale Mukositis durch systemische Tumortherapie. Im Focus Onkologie. 20(7-8). 36–38.
2.
Nicolatou‐Galitis, Ourania, Joanne M. Bowen, Mario Di Palma, et al.. (2013). Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients. Supportive Care in Cancer. 21(11). 3179–3189. 81 indexed citations
3.
Nicolatou‐Galitis, Ourania, Joanne M. Bowen, Mario Di Palma, et al.. (2012). Systematic review of amifostine for the management of oral mucositis in cancer patients. Supportive Care in Cancer. 21(1). 357–364. 80 indexed citations
4.
Bensadoun, René‐Jean, D. Riesenbeck, Peter B. Lockhart, et al.. (2010). A systematic review of trismus induced by cancer therapies in head and neck cancer patients. Supportive Care in Cancer. 18(8). 1033–1038. 155 indexed citations
5.
Dörr, Wolfgang, E. Dörr, Julia Haagen, et al.. (2010). [Side effects of radiotherapy in the oral cavity].. PubMed. 152(46). 37–9. 1 indexed citations
6.
Büntzel, Jens, D. Riesenbeck, Markus Glatzel, et al.. (2010). Limited effects of selenium substitution in the prevention of radiation-associated toxicities. results of a randomized study in head and neck cancer patients.. PubMed. 30(5). 1829–32. 39 indexed citations
7.
Thomas, Michael, Christian Rübe, Petra Hoffknecht, et al.. (2008). Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer. The Lancet Oncology. 9(7). 636–648. 229 indexed citations
8.
Dörr, Wolfgang, Thomas Herrmann, Bernd Reitemeier, D. Riesenbeck, & Knut A. Grötz. (2008). Folgen der Strahlentherapie in der Mundhöhle. 2(6). 543–569. 1 indexed citations
9.
Riesenbeck, D.. (2007). Supportivtherapie für bestrahlte Patienten. Der Onkologe. 13(3). 275–286.
10.
Bruns, Frank, Markus Glatzel, K. Schönekaes, et al.. (2006). Complementary and alternative medicine experience in radiation oncology patients: first results of a multi-center approach. Trace Elements and Electrolytes. 23(10). 318–325. 6 indexed citations
11.
Schuck, Andreas, Jürgen Brämswig, Stefan Könemann, et al.. (2005). Ovarian Function Following Pelvic Irradiation in Prepubertal and Pubertal Girls and Young Adult Women. Strahlentherapie und Onkologie. 181(8). 534–539. 34 indexed citations
12.
Riesenbeck, D., et al.. (2005). Heterogeneity of radiation induced apoptosis in Ewing Tumor cell lines characterized on a single cell level. APOPTOSIS. 10(1). 177–184. 8 indexed citations
13.
Könemann, Stefan, Tobias Bölling, D. Riesenbeck, et al.. (2004). Changed adhesion molecule profile of Ewing tumor cell lines and xenografts under the influence of ionizing radiation.. PubMed. 24(3a). 1637–44. 9 indexed citations
15.
Schumacher, Andrea, D. Riesenbeck, Achim Heinecke, et al.. (2003). Combined modality treatment for locally advanced non-small cell lung cancer: preoperative chemoradiation does not result in a poorer quality of life. Lung Cancer. 44(1). 89–97. 12 indexed citations
16.
Könemann, Stephanie, Tobias Bölling, D. Riesenbeck, et al.. (2003). Effect of radiation on Ewing tumour subpopulations characterized on a single-cell level: intracellular cytokine, immunophenotypic, DNA and apoptotic profile. International Journal of Radiation Biology. 79(3). 181–192. 5 indexed citations
17.
Könemann, Stephanie, Tobias Bölling, D. Riesenbeck, et al.. (2003). Time‐ and dose‐dependent changes of intracellular cytokine and cytokine receptor profile of Ewing tumour subpopulations under the influence of ionizing radiation. International Journal of Radiation Biology. 79(11). 897–909. 9 indexed citations
18.
Riesenbeck, D., Petra Feyer, & Irenä us A. Adamietz. (2003). Supportivtherapie in der Radioonkologie. Der Onkologe. 9(5). 519–529.
19.
Micke, Oliver, Jens Büntzel, Markus Glatzel, et al.. (2002). Use of complementary and alternative medicine in radiotherapy patients-results of a german multicenter study. International Journal of Radiation Oncology*Biology*Physics. 54(2). 50–50. 3 indexed citations
20.
Grötz, Knut A., D. Riesenbeck, M. Heinrich Seegenschmiedt, et al.. (2001). Chronische Strahlenfolgen an den Zahnhartgeweben (“Strahlenkaries”) Klassifikation und Behandlungsansätze. Strahlentherapie und Onkologie. 177(2). 96–104. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026